Innovating Works
MARKinPATH: Clinical validation of a bioMARKer for use in INtestinal PATHologies VENTER PHARMA tramitó un H2020: H2020-SMEInst-2014-2015 MARKinPATH global innovation project aims at undertake the clinical validation of Xylose, after ingestion of Gaxilose, as a Biomarker of int...
2014-09-08 - 2015-02-28 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.